✦ LIBER ✦

Alendronic acid, gatifloxacin, sertaconazole and zoledronic acid launched in Malaysia

Book ID: 120863065
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2002
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200213300-00054

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Zoledronic acid enhances bone-implant os

Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats

✍ B. Chen, Y. Li, X Yang, H. Xu, D. Xie 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 205 KB

Intravenous zoledronic acid and oral ale

Intravenous zoledronic acid and oral alendronate in patients with a low trauma fracture: experience from an osteoporosis clinic

✍ S. J. Craig; P. P. Youssef; J. H. Vaile; L. Sullivan; J. F. Bleasel 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB

Single infusion of zoledronic acid 5mg p

Single infusion of zoledronic acid 5mg provides sustained benefits in bone mineral density and biomarkers at 12 months in postmenopausal women with low bone mineral density and prior alendronate therapy

✍ McClung, Michael; Omizo, Molly; Minkoff, Jerome; Fiske, Darrell; Kriegman, Audre 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Quality of life and health status with z

Quality of life and health status with zoledronic acid and generic alendronate—a secondary analysis of the Rapid Onset and Sustained Efficacy (ROSE) study in postmenopausal women with low bone mass

✍ P. Hadji, V. Ziller, D. Gamerdinger, W. Spieler, K. Articus, M. Baier, R. Moeric 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 176 KB

Rapid Onset and Sustained Efficacy (ROSE

Rapid Onset and Sustained Efficacy (ROSE) study: results of a randomised, multicentre trial comparing the effect of zoledronic acid or alendronate on bone metabolism in postmenopausal women with low bone mass

✍ P. Hadji; D. Gamerdinger; W. Spieler; P. H. Kann; H. Loeffler; K. Articus; R. Mö 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 228 KB

Efficacy and safety of a once-yearly i.v

Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: A randomized, multicenter, double-blind, active-controlled study

✍ Eric S Orwoll; Paul D Miller; Jonathan D Adachi; Jacques Brown; Robert A Adler; 📂 Article 📅 2010 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 216 KB

## Abstract Zoledronic acid (ZOL) has shown beneficial effects on bone turnover and bone mineral density (BMD) in postmenopausal osteoporosis. This study compared the efficacy and safety of a once‐yearly i.v. infusion of ZOL with weekly oral alendronate (ALN) in men with osteoporosis. In this multi